OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Omicron variant evolution on vaccines and monoclonal antibodies
Michela Sabbatucci, Antonio Vitiello, Salvatore Clemente, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1779-1788
Open Access | Times Cited: 25
Michela Sabbatucci, Antonio Vitiello, Salvatore Clemente, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1779-1788
Open Access | Times Cited: 25
Showing 25 citing articles:
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
Kim Linton, Umberto Vitolo, Wojciech Jurczak, et al.
The Lancet Haematology (2024) Vol. 11, Iss. 8, pp. e593-e605
Closed Access | Times Cited: 25
Kim Linton, Umberto Vitolo, Wojciech Jurczak, et al.
The Lancet Haematology (2024) Vol. 11, Iss. 8, pp. e593-e605
Closed Access | Times Cited: 25
Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness
Wenhao Liu, Zehong Huang, Jin Xiao, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 184-184
Open Access | Times Cited: 20
Wenhao Liu, Zehong Huang, Jin Xiao, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 184-184
Open Access | Times Cited: 20
SARS-CoV-2 Drug Resistance and Therapeutic Approaches
Sania Batool, Santosh Chokkakula, Ju Hwan Jeong, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41980-e41980
Open Access | Times Cited: 3
Sania Batool, Santosh Chokkakula, Ju Hwan Jeong, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41980-e41980
Open Access | Times Cited: 3
Trend analysis of proton pump inhibitor consumption and expenditure: The real-world evidence
Francesco Ferrara, Maurizio Capuozzo, Venere Celotto, et al.
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 3, pp. 645-651
Closed Access | Times Cited: 6
Francesco Ferrara, Maurizio Capuozzo, Venere Celotto, et al.
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 3, pp. 645-651
Closed Access | Times Cited: 6
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
Catherine Thiéblemont, Yasmin Karimi, Hervé Ghesquières, et al.
Leukemia (2024) Vol. 38, Iss. 12, pp. 2653-2662
Open Access | Times Cited: 6
Catherine Thiéblemont, Yasmin Karimi, Hervé Ghesquières, et al.
Leukemia (2024) Vol. 38, Iss. 12, pp. 2653-2662
Open Access | Times Cited: 6
A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Zhe Chen, Leilei Feng, Lei Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Zhe Chen, Leilei Feng, Lei Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
The Impact of Antimicrobial Resistance in Cystic Fibrosis
Antonio Vitiello, Francesco Blasi, Michela Sabbatucci, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1711-1711
Open Access | Times Cited: 4
Antonio Vitiello, Francesco Blasi, Michela Sabbatucci, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1711-1711
Open Access | Times Cited: 4
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic
Jonatan J. Carvajal, Valeria García-Castillo, Shelsy V. Cuellar, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Jonatan J. Carvajal, Valeria García-Castillo, Shelsy V. Cuellar, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Biological and glucocorticoids treatment impair the medium-term immunogenicity to SARS-CoV-2 mRNA vaccines in autoimmune inflammatory rheumatic diseases
S. Garcia-Cirera, Joan Calvet, Juan Francisco Delgado de la Poza, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
S. Garcia-Cirera, Joan Calvet, Juan Francisco Delgado de la Poza, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Recent advances in chemometric modelling of inhibitors against SARS-CoV-2
Qianqian Wang, Xinyi Lu, Runqing Jia, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24209-e24209
Open Access | Times Cited: 2
Qianqian Wang, Xinyi Lu, Runqing Jia, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24209-e24209
Open Access | Times Cited: 2
First report on the QSAR modelling and multistep virtual screening of the inhibitors of nonstructural protein Nsp14 of SARS-CoV-2: Reducing unnecessary chemical synthesis and experimental tests
Qianqian Wang, Tengjiao Fan, Runqing Jia, et al.
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 3, pp. 105614-105614
Open Access | Times Cited: 2
Qianqian Wang, Tengjiao Fan, Runqing Jia, et al.
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 3, pp. 105614-105614
Open Access | Times Cited: 2
A Short Update on the Use of Monoclonal Antibodies in COVID-19
Antonio Vitiello, Michela Sabbatucci, Annarita Ponzo, et al.
The AAPS Journal (2024) Vol. 26, Iss. 2
Closed Access | Times Cited: 2
Antonio Vitiello, Michela Sabbatucci, Annarita Ponzo, et al.
The AAPS Journal (2024) Vol. 26, Iss. 2
Closed Access | Times Cited: 2
Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey
José R. Mediavilla, Tara Lozy, Annie Lee, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1699-1699
Open Access | Times Cited: 4
José R. Mediavilla, Tara Lozy, Annie Lee, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1699-1699
Open Access | Times Cited: 4
Molecular and Clinical Epidemiology of SARS-CoV-2 Infection Among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey
José R. Mediavilla, Tara Lozy, Annie Lee, et al.
(2023)
Open Access | Times Cited: 3
José R. Mediavilla, Tara Lozy, Annie Lee, et al.
(2023)
Open Access | Times Cited: 3
COVID-19 Bivalent Booster in Pregnancy: Maternal and Neonatal Antibody Response to Omicron BA.5, BQ.1, BF.7 and XBB.1.5 SARS-CoV-2
Wei‐Chun Chen, Shu-Yu Hu, Ching‐Fen Shen, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1425-1425
Open Access | Times Cited: 3
Wei‐Chun Chen, Shu-Yu Hu, Ching‐Fen Shen, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1425-1425
Open Access | Times Cited: 3
Neonatal and infant infection with SARS-CoV-2
Logan Grimes, Jeffrey S. Gerber
Seminars in Perinatology (2024) Vol. 48, Iss. 4, pp. 151922-151922
Closed Access
Logan Grimes, Jeffrey S. Gerber
Seminars in Perinatology (2024) Vol. 48, Iss. 4, pp. 151922-151922
Closed Access
Therapeutic Strategies to Combat Increasing Rates of Multidrug Resistant Pathogens
Antonio Vitiello, Giovanni Rezza, Andrea Silenzi, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 8, pp. 1557-1571
Closed Access
Antonio Vitiello, Giovanni Rezza, Andrea Silenzi, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 8, pp. 1557-1571
Closed Access
The influence of Omicron on vaccine efficacy and durability: a neurology perspective
Jethendra Kumar Muruganantham, Ramakrishnan Veerabathiran
Clinical and Experimental Vaccine Research (2024) Vol. 13, Iss. 3, pp. 175-175
Open Access
Jethendra Kumar Muruganantham, Ramakrishnan Veerabathiran
Clinical and Experimental Vaccine Research (2024) Vol. 13, Iss. 3, pp. 175-175
Open Access
COVID-19 mortality in different areas of Chinese mainland as of March 10, 2022
Yuehai Wang, Jinghong Yu, Xinzheng Wang
Research Square (Research Square) (2024)
Open Access
Yuehai Wang, Jinghong Yu, Xinzheng Wang
Research Square (Research Square) (2024)
Open Access
Antimicrobial resistance: strategies to counter it and Italian actions
Antonio Vitiello, Michela Sabbatucci, Andrea Zovi
Ethics Medicine and Public Health (2024) Vol. 32, pp. 101019-101019
Closed Access
Antonio Vitiello, Michela Sabbatucci, Andrea Zovi
Ethics Medicine and Public Health (2024) Vol. 32, pp. 101019-101019
Closed Access
Characterization of the viral genome of Omicron variants of SARS-CoV-2 circulating in Tripura, a remote frontier state in Northeastern India
Ankan Chakrabarti, Saikat Majumder, Apurba Sarkar, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access
Ankan Chakrabarti, Saikat Majumder, Apurba Sarkar, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access
Targeting protein homeostasis with small molecules as a strategy for the development of pan-coronavirus antiviral therapies
Yu-Qian Mao, Shahrzad Jahanshahi, Ramy Malty, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access
Yu-Qian Mao, Shahrzad Jahanshahi, Ramy Malty, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access
Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan
Chanroth Chhoung, Ko Ko, Serge Ouoba, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access
Chanroth Chhoung, Ko Ko, Serge Ouoba, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access
“Internet+” pharmacy in psychiatric hospital amid COVID-19 and post-pandemic period: analysis and development
Weiming Xie, Fei Wang, Yuanyuan Qian, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Weiming Xie, Fei Wang, Yuanyuan Qian, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)
Ignasi Esteban, Carmen Pastor-Quiñones, Lorena Usero, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 15-15
Open Access
Ignasi Esteban, Carmen Pastor-Quiñones, Lorena Usero, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 15-15
Open Access
